Insider Transactions Reported by 14 Insiders of Ovid Therapeutics Inc.

Symbol
OVID on Nasdaq
Location
New York, NY

Insiders trading volume in the past year

Ovid Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
TAKEDA PHARMACEUTICAL CO LTD 10%+ Owner $11,680,054 08 Dec 2025
JEREMY M. LEVIN Director $5,584,763 26 Feb 2026
Amit Rakhit President and CMO $1,562,669 14 Jul 2021
Jeffrey A. Rona Cbfo $237,595 -$12,384 -5% 23 Feb 2026
STELIOS PAPADOPOULOS Director $112,000 26 Feb 2026
MARGARET A. ALEXANDER President and CEO, Director $89,537 -$16,901 -16% 23 Feb 2026
Jason Tardio Chief Operating Officer $60,469 22 Feb 2024
Thomas Michael Perone General Counsel, Secretary $60,469 22 Feb 2024
Kevin Joseph Fitzgerald Director 26 Feb 2026
Robert Michael Poole Director 22 Feb 2024
DOUGLAS E. WILLIAMS Director 17 May 2021
Bart Friedman Director 26 Feb 2026
Karen Bernstein Director 26 Feb 2026
Barbara Gayle Duncan Director 26 Feb 2026

Recent Insider Transactions by Companies or Individuals for Ovid Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.